Target intelligence / Profile preview

Protozoan ribosomal RNA (rRNA)

Target
rRNA
Molecular classification
Ribosomal RNA, Nucleic acid
01

Overview

Protozoan ribosomal RNA (rRNA) is a fundamental component of the protein-synthesizing machinery in protozoal parasites, serving as the structural and catalytic core of the ribosome (PubMed: 11585578). In protozoa, the ribosome consists of a small subunit (containing 18S rRNA) and a large subunit (containing 28S, 5.8S, and 5S rRNA), which exhibit significant structural differences from human cytoplasmic ribosomes (JBC: 10.1074/jbc.M110.203539). Certain antibiotics, most notably the aminoglycoside paromomycin, selectively target the decoding A-site of the protozoan 18S rRNA (StatPearls: NBK545207). This binding induces conformational changes that interfere with the accuracy of translation, leading to the incorporation of incorrect amino acids or the premature termination of protein synthesis (PubMed: 17071588). This disruption is lethal to various protozoan pathogens, including Leishmania, Entamoeba histolytica, and Giardia (CDC: Parasites - Leishmaniasis). Because of its essential role in parasite viability and its structural divergence from host rRNA, it serves as a validated target for antiparasitic therapy and a primary tool for molecular diagnostics (PubMed: 25135930).

Other names
Protozoal ribosomal RNA18S ribosomal RNA28S ribosomal RNASmall subunit ribosomal RNALarge subunit ribosomal RNASSU rRNALSU rRNA
02

Mechanism of action

Inhibition of protein synthesis by binding to the aminoacyl-tRNA site (A-site) of the small ribosomal subunit (18S rRNA), inducing conformational changes that lead to mRNA misreading and premature termination of translation (StatPearls: NBK545207; PubMed: 17071588).

03

Biological functions

Protein synthesisTranslationRibosome assemblyCatalysis of peptide bond formation
04

Disease associations

InfectionLeishmaniasisAmoebiasisGiardiasisCryptosporidiosisTrichomoniasis
05

Safety considerations

OtotoxicityNephrotoxicityGastrointestinal distressInjection site painPotential for cross-resistance with other aminoglycosides (StatPearls: NBK545207).
06

Interacting drugs

Paromomycin

1 more in the full profile.

07

Biomarkers

18S rRNA gene sequenceParasite nucleic acid load

Beyond the preview

Go deeper on Protozoan ribosomal RNA (rRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protozoan ribosomal RNA (rRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call